Glutamine consumption is enhanced in cancer cells,89 and high expression of SLC1A5 (ASCT2), the major glutamine transporter, is correlated both to the levels of MYCN as well as the activating transcription factor 4 (ATF4) in NB cells. The gene discussed is MYCN; the disease is neuroblastoma.